DGCI gives nod for Covaxin Phase II/III trials on 2-18 year olds

Credit: IndiaTimes- Published on May 13, 2021
The Indian drugs regulator, the Drugs Controller General of India (DCGI) has granted its approval to indigenously developed Covid-19 vaccine Covaxin’s developer Bharat Biotech for conducting Phase II/III clinical trials of the desi vaccine on children from 2 to 18 years of age. The children’s trials will be carried out on 525...

You are here

💡 newsR Knowledge: Other News Mentions


Vaccine against COVID-19
Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotech’s expression of..
Credit: IndiaTimes - Published 20 hours ago

The World Health Organisation (WHO) has accepted Bharat Biotech’s expression of interest (EoI) for the emergency use listing (EUL) of India's first..
Credit: IndiaTimes - Published 1 day ago

Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use..
Credit: IndiaTimes - Published 1 day ago


Disease caused by severe acute respiratory syndrome coronavirus 2
Studies show that vaccinations can help reduce post-Covid hospitalisation by almost 75-80 per cent and bring down oxygen requirement to just 8%, the government..
Credit: IndiaTimes - Published 2 hours ago

Bharat Biotech

Indian biotechnology company and vaccine manufacturer
The final vaccine does not contain newborn calf serum at all as the calf serum is not an ingredient of the final vaccine product, Health Ministry said
Credit: DNA - Published 2 days ago

Related videos from verified sources

Mom of newborn qualifies for U.S. Olympic trials in stunning 32-minute 10k: 'Why am I bawl 01:00
Credit: In The Know Wibbitz - Published 1 week ago 

Covid-19: Aiims Delhi to begin Covaxin clinical trials for Children from today | Oneindia News 01:24
Credit: Oneindia - Published 2 weeks ago 

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials 01:59
Credit: ANI - Published on May 9, 2021 

You might like